WilmerHale Counsels Cynosure in $1.65B Acquisition by Hologic

WilmerHale Counsels Cynosure in $1.65B Acquisition by Hologic

Firm News

Related Solutions

Lawyers with deep and broad experience counseling clients in every industry on the design, implementation, and interpretation of executive compensation arrangements and on general compensation and benefits issues.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.

Cynosure (Nasdaq: CYNO), a developer and manufacturer of aesthetic treatment systems, and Hologic (Nasdaq: HOLX), a developer, manufacturer and supplier of diagnostics, medical imaging and surgical products, today announced the sale of Cynosure to Hologic in a transaction worth approximately $1.65 billion. The transaction is expected to close during late March or April of 2017.

The WilmerHale team on the transaction was led by Hal Leibowitz and Jason Kropp and included Andrew Bonnes, Kim Wethly, Leon Greenfield, Bruce Manheim, Steve Barrett, Laura Schneider, Amy Null, Julie Hogan Rodgers, Ciara Baker, Davis Sluis, Caroline Dotolo, Leah Segal and Alex Civetta. 

Read the press release for more information. 

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel